Human circadian system causes a morning peak in prothrombotic plasminogen activator inhibitor-1 (PAI-1) independent of the sleep/wake cycle

被引:125
作者
Scheer, Frank A. J. L. [1 ,2 ]
Shea, Steven A. [1 ,2 ,3 ]
机构
[1] Brigham & Womens Hosp, Div Sleep Med, Med Chronobiol Program, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA
基金
美国国家卫生研究院;
关键词
MYOCARDIAL-INFARCTION; FIBRINOLYTIC-ACTIVITY; RHYTHM; GENE; FLUCTUATIONS; OSCILLATION; COMPONENTS; EXERCISE; PROMOTER; BLOOD;
D O I
10.1182/blood-2013-07-517060
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Serious adverse cardiovascular events peak in the morning, possibly related to increased thrombosis in critical vessels. Plasminogen activator inhibitor-1 (PAI-1), which inhibits fibrinolysis, is a key circulating prothrombotic factor that rises in the morning in humans. We tested whether this morning peak in PAI-1 is caused by the internal circadian system or by behaviors that typically occur in the morning, such as altered posture and physical activity. Twelve healthy adults underwent a 2-week protocol that enabled the distinction of endogenous circadian effects from behavioral and environmental effects. The results demonstrated a robust circadian rhythm in circulating PAI-1 with a peak corresponding to similar to 6:30 AM. This rhythm in PAI-1 was 8-times larger than changes in PAI-1 induced by standardized behavioral stressors, including head-up tilt and 15-minute cycle exercise. If this large endogenous morning peak in PAI-1 persists in vulnerable individuals, it could help explain the morning peak in adverse cardiovascular events.
引用
收藏
页码:590 / 593
页数:4
相关论文
共 50 条
  • [31] Bezafibrate Induces Plasminogen Activator Inhibitor-1 Gene Expression in a CLOCK-Dependent Circadian Manner
    Oishi, Katsutaka
    Koyanagi, Satoru
    Matsunaga, Naoya
    Kadota, Koji
    Ikeda, Eriko
    Hayashida, Satoru
    Kuramoto, Yukako
    Shimeno, Hiroshi
    Soeda, Shinji
    Ohdo, Shigehiro
    MOLECULAR PHARMACOLOGY, 2010, 78 (01) : 135 - 141
  • [32] Circadian locomotor output cycles kaput accelerates atherosclerotic plaque formation by upregulating plasminogen activator inhibitor-1 expression
    Jiang, Qixia
    Liu, Hua
    Wang, Shengyun
    Wang, Jiamei
    Tang, Yehua
    He, Zhiqing
    Wu, Feng
    Huang, Zhigang
    Cong, Xiaoliang
    Ding, Ru
    Liang, Chun
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2018, 50 (09) : 869 - 879
  • [33] Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity
    Castelló, R
    España, F
    Vázquez, C
    Fuster, C
    Almenar, SM
    Aznar, J
    Estellés, A
    THROMBOSIS RESEARCH, 2006, 117 (05) : 487 - 492
  • [34] Validation of an immunoassay to measure plasminogen-activator inhibitor-1 concentrations in human saliva
    Zhang, Xi
    Dimeski, Goce
    Punyadeera, Chamindie
    BIOCHEMIA MEDICA, 2014, 24 (02) : 258 - 265
  • [35] Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review
    Zhang, Qiang
    Jin, YunRui
    Li, XueMei
    Peng, XingQiao
    Peng, Na
    Song, JiFang
    Xu, Mingfang
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2020, 49 (02) : 141 - 146
  • [36] Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells
    Singh, Prachi
    Peterson, Timothy E.
    Barber, Kara R.
    Kuniyoshi, Fatima Sert
    Jensen, Andrus
    Hoffmann, Michal
    Shamsuzzaman, Abu S. M.
    Somers, Virend K.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 392 (01) : 47 - 52
  • [37] Association of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G and Apolipoprotein E polymorphisms with risk of Myocardial Infarction in Indian Tamil Population
    Sahana, Nair
    Vivekananda, Budamagunta
    Abinaya, Meenakshisundaram
    Hemapriyanka, S.
    Pournima, Prabhakaran
    Abirami, B. Suruthi
    Devi, A.
    ArulJothi, K. N.
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2018, 13 (01): : 91 - 98
  • [38] Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility A meta-analysis
    Zhang, Xin
    Gao, Bai
    Xu, Bing
    MEDICINE, 2020, 99 (50) : E23660
  • [39] Predictive role of plasminogen-activator-inhibitor-1 (PAI-1) in non-ST-segment elevation acute coronary syndrome
    A Sinkovic
    V Urlep-Salinovic
    Critical Care, 6 (Suppl 1):
  • [40] Accelerated thrombus lysis in the blood of plasminogen activator inhibitor deficient mice is inhibited by PAI-1 with a very long half-life
    Jankun, Jerzy
    Aleem, Ansari M.
    Struniawski, Radoslaw
    Lysiak-Szydlowska, Wieslawa
    Selman, Steven H.
    Skrzypczak-Jankun, Ewa
    PHARMACOLOGICAL REPORTS, 2009, 61 (04) : 673 - 680